QA: Hepion Pharmaceuticals Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001583771_2025_Hepion_Pharmaceuticals_Inc.pdf

Logs

Graph

Absolute values for 0001583771, Hepion Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 1,613,737
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 3,143,886
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 333,189
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,603,415
9 ResearchAndDevelopmentExpense 4,246,468
10 remainder_Expenses 1,950,984
11 remainder_Revenues 0
12 remainder_NetIncome 4,253,185
13 remainder_ComprehensiveNetIncome 81,548
  yvar yval
0 Assets 1,613,737
1 Liabilities 3,477,075
2 Expenses 13,800,867
3 Revenues 0
4 StockholdersEquity -1,863,338
5 NetIncome -9,547,682
6 ComprehensiveNetIncome -9,506,908
7 BaseVar 11,613,206
8 EconomicCapitalRatiobeforeLimitedLiability -5.33
9 EconomicCapitalRatio 0.145

Edgar->Model Mapping

Feature Distribution

Change over Time